Patent · US Active

Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene

US9315826B2 · kind B2 · utility

0Cited by
10References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 31, 2011
Grant dateApr 19, 2016
Priority date
Expiry dateJan 31, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/12171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention contemplates a new synthetic, codon-optimized Sin Nombre virus (SNV) full-length M gene open reading frame (ORF) that encodes a unique consensus amino acid sequence. The SNV ORF was cloned into a plasmid to form the first stable recombinant SNV full-length M gene that elicits neutralizing antibodies. The gene can be engineered into a vaccine system, and is useful to protect mammals against infection with Sin Nombre virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.